Research indicates that GPC3 expression is elevated in patients with HCC while it remains undetectable in healthy subjects and in those suffering from benign hepatic diseases, including dysplastic or cirrhotic nodules (23). Here, GPC3 is linked to hepatocellular carcinoma.